AVC-S-102

N/A

Report date: 2025/05/09 11:33:30

Base Information

Drug NameAVC-S-102
Drug Alias NameAVC-S-102
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Epidermal growth factor receptor erbB1
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvidicure BV
China Registration ClassN/A

Develop Information

Active CompaniesAvidicure BV
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A